For how we live.
Every article we have published on Global Burden Of Disease, newest first.
A Global Burden of Disease analysis finds the share of female breast-cancer deaths tied to high fasting plasma glucose rose from 1990 to 2023 and is projected to keep rising — but the design cannot prove causation.
A Global Burden of Disease analysis found early-neonatal mortality in Kazakhstan dropped about 33% from 2010 to 2023 — yet boys kept dying at higher rates than girls, a gap that only recently began to close.
A Global Burden of Disease analysis puts substance use disorder prevalence at 0.78% across the Arab League in 2023, about 63% below the global figure — yet women's opioid prevalence topped men's in 19 of 22 countries.
A Global Burden of Disease analysis of Kenya's 47 counties found ischaemic stroke killed 11,328 people in 2023 — death rates are falling even as new cases rise, with raised blood pressure behind 35% of the burden.
A Global Burden of Disease 2023 analysis of 31 countries finds the burden climbing, peaking in early adolescence and heavier in women, with population growth the single biggest driver.
A Global Burden of Disease 2023 analysis counts 241 million users worldwide, concentrated in south Asia, with a rising burden of stroke and oral cancer even as prevalence has barely moved.
An IARC worldwide incidence analysis puts the infection-attributable share at 12%, led by H pylori and HPV, with eastern Asia carrying the heaviest load and most of the toll preventable.
A regional Global Burden of Disease analysis attributes 15.8 million healthy life-years lost in 2023 to high body-mass index, and warns of a 346.3% rise in obesity among the young.
A study of 46 pathogens attributes about 66,400 child deaths in 2023 to Streptococcus pneumoniae across G20 countries, with the heaviest load falling on India, South Africa and Indonesia.
A pooled analysis of 315,403 adults finds wealth inequalities in hypertension, diabetes and cholesterol care grow across the care cascade — but the biggest treatment gaps are not where most heart risk could be averted.
A Global Burden of Disease 2023 study counts 1,102,794 incident tracheal, bronchus and lung cancers in Asians aged 60 and over in 2023, with ageing populations set to sustain the burden even as rates fall.
A Global Burden of Disease 2021 analysis of 5-to-9-year-olds finds falling disability rates worldwide, yet projects that South and Southeast Asia and sub-Saharan Africa will still carry the heaviest load.
A real condition with a formal case definition, a measurable population-level burden, and — so far — no treatment proven to reverse it. What the studies do and do not establish.
Resistance is not something your body develops. It is an evolutionary property of bacteria, spread on mobile pieces of DNA — and it was already linked to nearly 5 million deaths a year before the forecasts began.
The Global Burden of Disease estimates for anxiety disorders separate two things that public debate keeps merging: how many people have it, and how likely a given person is to. Diagnosis is a third question again.
New GBD analysis across 21 countries finds one group whose burden fell — children — while incidence rose 92% overall and the sex pattern inverted.
A Global Burden of Disease comparison puts the 2023 US maternal mortality rate at 33.8 per 100,000 live births, alongside cardio-kidney-metabolic risk burdens several times those of other high-income countries.
A single-author analysis of Global Burden of Disease estimates finds the region's neurodevelopmental picture split in two — and argues the flat autism curve reflects diagnostic capacity, not risk.
Global Burden of Disease data show prevalent traumatic brain injury cases in people aged 15-49 rose from 12.53 million in 1990 to 14.99 million in 2021, even as age-standardised rates fell.
Two November burden analyses put diabetes diagnosed before 40 on an upward path to 2050. In the Americas, Central Latin America carried the highest rates and men carried more of the burden than women.
A meta-regression across 28 countries put pooled prevalence near 4-5% and standardised mortality ratios between 1.8 and 4.7, in a condition the Global Burden of Disease study does not count.
A new GBD analysis puts sepsis-related deaths at 21.4 million, roughly double the 11.0 million estimated for 2017 — a change driven partly by COVID-19 and partly by a different method.
Age-standardised disability-adjusted life-years fell 12.6% since 2010, but the raw total rose 6.1% to 2.80 billion. Anxiety, depression and diabetes rose fastest even after adjusting for ageing.